May 31, 2017 - Life with MS -- this world MS day, here's a look at 5 stocks including Biogen (BIIB) that are key players in the multiple sclerosis (MS) market.
May 26, 2017 - Why Pfizer, Novartis, and Sanofi rank at the top of all dividend stocks in the generic-drug industry.
May 22, 2017 - Billionaires appear to have focused on drug stocks that were mired in debt in Q1.
May 22, 2017 - How did Teva perform in Q1?How's the plan of deleveraging going?Should you wait to buy until after Allergan dumps their shares?
May 19, 2017 - Amgen Inc. (AMGN) recently announced the submission of a biologics license application (BLA) to the FDA for its pipeline candidate erenumab (AMG 334) for the prevention of migraine.
May 19, 2017 - Valeant Pharmaceuticals International, Inc. (VRX) announced that it has decided to stay outstanding litigation and extend the 30-month stay regarding Teva's ANDA for a generic version of Xifaxan 550 mg tablets.
May 16, 2017 - Vanguard Health Care Fund Buys Abbott Laboratories, Tesaro Inc, Teva Pharmaceutical Industries, Sells St Jude Medical Inc, Incyte Corp, Amgen Inc, Stocks: ABT,TEVA,IONS,CTEC,01177,APN,TSRO,PTHN,CNC,HUM,INC, release date:May 16, 2017
May 16, 2017 - Reuters reports that Orange County, New York has filed a lawsuit against Johnson & Johnson (NYSE:JNJ), Teva Pharmaceutical Industries (NYSE:TEVA), Endo International (NASDAQ:ENDP) and other drug m
May 16, 2017 - Coatings specialist doesn't seem to know how to take "No" for an answer.
May 16, 2017 - Teva Pharmaceutical Industries Ltd. (TEVA) announced the launch of a generic version of Valeant Pharmaceuticals International, Inc.'s (VRX) diabetes drug, Glumetza, in the U.S.